The global gait rehabilitation system market size was US$ 136.8 billion in 2021. The global gait rehabilitation system market is forecast to grow to US$ 225.8 billion by 2030, registering a compound annual growth rate (CAGR) of 5.6% during the forecast period from 2022 to 2030. 

The gait rehabilitation system is highly used to provide physical therapy interventions with a robotic approach. This physical therapy intends to improve functional ambulation and offer efficient training. These systems are a significant component of the therapy offered to patients suffering from movement disorders of the lower extremities. 

Factors Influencing the Market

• The growing number of cases related to stroke and neurological disorders are driving the growth of the global gait rehabilitation system market. In addition, growing technological advancements by prominent players are forecast to surge the market growth in the coming years. Furthermore, the increasing geriatric population is increasing the cases of neurological disorders, which is contributing to the market growth. 
• The growing adoption of gait rehabilitation systems in nutraceutical industries will benefit the market during the forecast period. In addition, the market will witness favorable opportunities due to growing investments by major market players in capsule manufacturing plants. 
• Increasing healthcare expenditure is forecast to fuel the growth of the global gait rehabilitation system market. Governments of various countries are increasing healthcare expenditure and investing highly in order to offer superior quality services. Therefore, the adoption of gait rehabilitation systems is likely to accelerate globally. 
• The high cost of the gait rehabilitation system may hamper the overall market growth. 

COVID-19 Impact Analysis

The gait rehabilitation systems market suffered significant losses at the beginning of the COVID-19 crisis because of supply chain disruptions and lockdown restrictions imposed in most countries. COVID-19 has had a significant negative impact on the gait rehabilitation systems market. Moreover, the COVID-19 pandemic has deprived patients of taking neurological treatments. Moreover, self-rehabilitation became a progressive trend as people were not allowed to visit hospitals without COVID-19 tests. 

Regional Analysis

North America is forecast to have maximum contribution in the global gait rehabilitation system market due to the growing penetration of advanced technologies. In addition, high healthcare expenditure and growing government initiatives to offer efficient healthcare services are likely to drive the regional market growth. Furthermore, the increasing prevalence of strokes, mostly among the geriatric population, is contributing to the market growth. Moreover, growing product launches and R&D Activities will fuel the growth of the regional gait rehabilitation system market during the forecast period. 

Market Segmentation

The global gait rehabilitation system market segmentation focuses on Product, End-User, and Region. 

By Product

• Mechanical Type
• Computer-aided
• Others

By End-User

• Hospital
• Clinic
• Rehabilitation Center
• Other

By Region

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA
• South America
• Brazil
• Argentina
• Rest of South America

Competitors in the Market

• Lonza
• Pacific BioLabs
• Charles River
• Merck
• Eurofins
• Medicilon
• GenScript
• BioMérieux/Hyglos
• Accugen Labs
• Fujifilm
• Steris
• Nelson Laboratories
• Other prominent players